Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

AltaPointe Health Taking Steps to Stop Opioid Epidemic
  • USA - English


News provided by

AltaPointe Health

Oct 25, 2018, 03:00 ET

Share this article

Share toX

Share this article

Share toX

AltaPointe Health's corporate office is located in Mobile, Alabama.
AltaPointe Health's corporate office is located in Mobile, Alabama.

MOBILE, Ala. (PRWEB) October 25, 2018 -- In the Mobile Bay region, AltaPointe has helped people transition from uncontrollable opiate addiction to recovery through its Medication-Assisted Treatment since the 1970s. Today, more than 1,200 individuals receive treatment through AltaPointe Substance Abuse Services; 400 of them are enrolled in the medication-assisted treatment program.

“This problem is not going away unless we talk about it.Sometimes it takes less than the 30-day prescription for some people to become addicted."

Post this

“This problem is not going away unless we talk about it,” says Marianne Saitz, O.D., medication-assisted treatment medical director, who works to determine when individuals seeking help are a right fit for the AltaPointe MAT clinic and whether the clinic is right for them.

Lortab®, OxyContin®, Percocet®, Morphine®, and other abused and misused opioid prescriptions create such euphoric feelings for some individuals that they become addicted. Saitz recently gave her perspectives about the opioid epidemic and how Medication-Assisted Treatment can be the catalyst to overcoming addiction.

Dr. Saitz says over-prescribing opiates is cause of the crisis.

What do you believe has caused the widespread increase in opioid addiction and subsequent overdoses?
Saitz: The over-prescribing of opiates is the primary problem. Opioid painkillers are not necessary for some procedures. You don’t necessarily need Lortab when you have a tooth pulled. Tylenol® should suffice.

What drugs do you see as the most abused by AltaPointe consumers?
Saitz: AltaPointe providers say Lortab®, now known as Norco®, is the most abused drug.

How is prescribing an opioid painkiller related to addiction?
Saitz: The majority of addictions begin with a prescription from a doctor. When an individual takes the opioid because of the euphoric feeling they get, they often can tell they’re getting into trouble. However, they don’t talk to their doctor about this because they know the doctor will cut off their prescription, basically firing the patient. When this happens, the patient is not referred to substance use treatment or weaned off the medication. They are physically addicted to painkillers and need medical help to get off the drug

When can a physician tell that patients are in trouble with opiates?
Saitz: There is a change in the patient’s behavior. They request early refills using excuses such as they lost the bottle or the dog ate it. Another way they find out is when a patient visits the ER and gets another opioid prescription. The ER is required to report the prescription to the Alabama Prescription Drug Monitoring Program, a registry of all controlled substances prescribed in the state.

How much time does it take to become addicted?
Saitz: Sometimes it takes less than the 30-day prescription for some people.

What is happening in the brain that makes someone susceptible to addiction?
Saitz: Opioid use can change brain chemistry. The body reports to the brain that it is gaining pleasure from the opiate, which reinforces the need to take the medication. When someone addicted to opioids stops taking the drug, for weeks they are very sick and feel like they have the worst-ever case of flu. Taking more opiates to feed the brain’s need for the drug is what gets them out of bed every day.

Why is MAT the best option for many to recover from addiction?
Saitz: Replacing the illicit opiate with medications such as Methadone® or Suboxone® will control withdrawals and cravings. People do not get high from these medications. They help keep them from not being sick and keep them in and out of constant withdrawals. Seeing the patients every day for the first 90 days also is part of the reason why MAT is so effective. It allows them to feel normal and to be able to function. They are no longer sick and no longer chasing the high. They can repair damaged relationships and can hold down jobs that they were not able to do when they are using.

What advice would you give someone wanting to help an addict?
Saitz: When you suspect someone of having an opioid addiction, it is always best to not accuse them. Say that you’re very concerned, that you’ve noticed changes in behavior or in their personality and that you’re worried they may have a problem. Many people don’t know there is help for their problem or that it is a treatable disease. It would make it easier for someone that seeks help to have a friend or loved one accompany them to treatment the first time they go. You wouldn’t sit in on any conversations or the assessment. You would merely drive them to the location, sit in the waiting room; provide that sort of support.

When is it acceptable to call your loved one’s doctor about his or her addiction?
Saitz: When you think someone has gotten to the point that they’re doctor shopping or getting drugs their doctor doesn’t know about, it quickly can become a matter of life or death. That’s when you should call their doctor and say, “You’re prescribing ‘x’ medication for my son or daughter, and they’re also doing this or that.” It is not a HIPAA violation, and frequently doctors have no idea their patient is mixing prescribed meds with other things.

What should the public know to prevent addiction or identify someone who has an opioid addiction?
Saitz: The public needs to know this is a disease that creates a difference in brain chemistry or brain receptors for people who become addicted. If you need help or know someone that needs help, you can go to your primary care physician where your doctor will link you to services.

Is there one primary barrier to treatment?
Saitz: People with jobs are afraid of being fired if their employer learns they have an addiction. That happens because most employers don’t view addiction as a disease.

AltaPointe offers FREE medication-assisted treatment to qualifying individuals in the Mobile Bay region. For more information, please call (251) 666-2569.

April Douglas, Director of Public Relations, AltaPointe Health, +1 (251) 544-4639, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.